Clinical Trials
28 trialsPhase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Novartis
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
Huahui Health
Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Beijing DCTY Biotech Co.,Ltd.
TCR1188-ABC Cells in KRAS-mutated Cancers
University of Pennsylvania
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
ODI-2001-01
Centre Georges Francois Leclerc
A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas
Cedars-Sinai Medical Center
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
Philogen S.p.A.
TRIUNITE06
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
CT-202
Context Therapeutics Inc.
A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
DUNP19
Radiopharm Theranostics, Ltd
PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases
Chinese PLA General Hospital
YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment
West China Hospital
Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
City of Hope Medical Center
First in Human Study of QLS5316 in Solid Tumors
Qilu Pharmaceutical Co., Ltd.
A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer
China Medical University, China
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
Shanghai Bao Pharmaceuticals Co., Ltd.
PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
The First Hospital of Jilin University
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
LICoRN-01
Assistance Publique - Hôpitaux de Paris
Efficacy and Safety of Trifluridine/tipiracil (TAS-102) Combined with Bevacizumab and Putalimab in the Treatment of Patients with MCRC After Cytoreductive Surgery: a Single-arm, Single-center Clinical Study
Second Affiliated Hospital, School of Medicine, Zhejiang University
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.
Beijing SonoPhotoNano Medical Technology Co., Ltd.
AROG4-01-01
Aromics Therapeutics
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
Danatlas Pharmaceuticals Co., Ltd